FDA approves nivolumab with ipilimumab for unresectable or metastatic MSI-H or dMMR colorectal cancer
By
RAJLAXMI
Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
By
RAJLAXMI
FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
By
RAJLAXMI

India's DMPLOI - Jobs & Networking App